Drug Safety is the official journal of the International Society of Pharmacovigilance (ISoP). The official representative for the Society is Dr Angela Caro Rojas, ISoP President (administration@isoponline.org). Contact: For more information about the journal, including pre-submission enquiries, please...
Go to submission site Journal overview Aims and scope Journal metricsEditorial board Expert Opinion on Drug Safety[ISSN 1474-0338]; [e- ISSN 1744-764X] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles on all aspects of drug safety, ...
Shaping secondary pharmacology panels of the future: evolving target selection criteria for safety panels Friedemann Schmidt Richard J. Brennan Jean-Pierre Valentin Correspondence22 Apr 2025Nature Reviews Drug Discovery P: 1-3 Human intestinal immuno-organoids ...
Current Drug Safety Articles & Issues Submit search About the journal Journal home page Author Guidelines Link to the published Contents Articles Case reportOpen access Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A ...
An international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery. The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiol...
and Y.S. made substantial contributions to discussion of the content, writing of the manuscript and reviewing the manuscript before submission. Corresponding author Correspondence to Tal Burt. Ethics declarations Competing interests Y.B. is President of the Phase-0/Microdosing Network, a non-profit ...
SKMC senior management has made a commitment to make quality and patient safety a top priority. Medication errors is one of the major causes of morbidity and mortality in hospitalized patients. Medication reconciliation has been shown to significantly reduce medication errors resulting in better ...
Article Publishing Charge (APC):USD 5,550 (excluding taxes).The amount you pay may be reduced during submission if applicable. Reviewthis journal’s open access policy. Subscription No publication fee charged to authors, and published articles are immediately available to subscribers. ...
All authors contributed substantially to discussion of the content and/or edited the manuscript before submission. Corresponding author Correspondence to Charles Dumontet. Ethics declarations Competing interests C.D. has received research funding from Pierre Fabre and Sanofi, and has worked as a ...
Reviewthis journal’s open access policy. 7 days Time to first decision 77 days Review time 81 days Submission to acceptance 10 days Acceptance to publication View all insights Co Editor-in-Chief View full editorial board Professor Ming-Wei Wang, MD, PhD ...